chartexchange

CSTL
Castle Biosciences, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:50 PM EST
33.38USD+1.213%(+0.40)380,905
After-hoursNov 18, 2026 4:00:30 PM EST
33.38USD0.000%(-0.00)
Loading…
Loading…
Healthcare
Diagnostics & Research
HQ
Friendswood, TX, USA
Previous Close
$32.98
Beta
1.11
52-Week High
$44.28 2026-01-26
52-Week Low
$17.72 2026-05-14
SMA 50
$34.37
SMA 200
$28.09
Avg. Vol 10D
515,123
Avg. Vol 30D
405,515
Avg. Vol 90D
409,374
Relative Vol
0.94
27.48M
0.2800%
2,200,000
125
CSTL Profile

castle biosciences, inc. specializes in diagnostic tests for cancers. founded in 2008, the company goal has been to help advance the care for cancers through objective testing. our team works with outstanding members of the oncology community throughout the discovery, development and utilization of these tests. currently, castle biosciences has tests to help doctors treat cutaneous melanoma, uveal melanoma, esophageal adenocarcinoma, mesothelioma and glioma. we have active research programs in rectal cancer and soft tissue sarcoma, and anticipate tests for these and other under-served cancers to be available in the near future please visit us at www.castlebiosciences.com for more information on our company and products.

CSTL Performance
PeriodPriceDateChangeBeta
1W34.502026-11-12-3.07%1.581
1M32.172026-10-19+3.96%1.425
3M32.322026-08-19+3.46%1.093
6M19.202026-05-19+74.17%1.048
1Y34.652025-11-19-3.49%1.115
2Y28.872024-11-19+15.83%—
5Y47.502021-11-19-29.60%1.409
CSTL Stock Summary

Castle Biosciences, Inc. Common Stock (NASDAQ:CSTL) stock price today is $33.44, and today's volume is 380,905. CSTL is up 1.395% today. The 30 day average volume is 405,515. CSTL market cap is $1.03B with 30.82M shares outstanding.